Enliven Therapeutics, Inc.
USD51.73
+0.89 (+1.74%)
CEO
Richard A. Fair
IPO Date
2020-03-12
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$51.49
Prev. Close
$50.85
Day Low
$50.48
Day High
$52.00
52W Low
$14.79
52W High
$52.00
Market Cap
$3.70B
Volume
0.16M
| -11.9 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -29.1% | -26.3% | 0.00 | 10.28 | -6.9 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | 49.0% | -45.2% | -0.00 | 8.00 | -2.7 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -23.2% | -21.8% | 0.00 | 19.24 | -2.8 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -22.5% | -20.9% | 0.00 | 14.47 | -20.4 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | 48.0% | -70.5% | 0.00 | 7.29 | -11.0 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | 43.1% | -147.1% | 0.00 | 4.21 | -22.9 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | 0.0% | 0.0% | -0.04 | 12.38 | 0.0 |
| -7.4 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -4.2% | -4.1% | 0.00 | 32.95 | -15.8 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -5.2% | -5.0% | 0.00 | 32.58 | -10.3 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -9.9% | -9.4% | 0.00 | 21.06 | -8.6 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -7.5% | -7.1% | 0.00 | 19.99 | -12.1 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -8.0% | -7.6% | 0.00 | 17.44 | -13.3 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -6.5% | -6.1% | 0.00 | 14.39 | -13.7 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -7.2% | -6.6% | 0.00 | 13.47 | -8.7 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -7.9% | -7.1% | 0.00 | 10.28 | -7.3 |